Viewing Study NCT04116918


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-03-01 @ 1:43 PM
Study NCT ID: NCT04116918
Status: UNKNOWN
Last Update Posted: 2019-10-07
First Post: 2019-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC
Sponsor: Baodong Qin
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC Stage IV View
None EGFR T790M-negative View
None Anlotinib View
None JS001 View
Keywords: